>>> US Gapping up

Gapping up

In reaction to strong earnings/guidance: RUBI +21.9% (also upgraded at RBC Capital Mkts and at Opco), ARTX +18.5%, NTWK +10.1%, PSDV +8.5% (thinly traded), SWAY +6.5%, CEL +5.2% (light volume), FIVN +4.6% (light volume), AG +3.6%, AMBR +2.6%, IOC +2.3%, EZCH +2.3%, (light volume), CYCC +2.2%, (light volume), M +1.8%, (also increases dividend by 25% and raises share repurchase authorization by $1.5 billion).

Metals/mining stocks trading higher: NEM +1.7%, MT +1.5%, GG +1.3%, SLV +1.2%, GDX +1.1%, SLW +1.1%, GFI +0.8%, RIO +0.6% (Rio Tinto says Vale dispute will not alter plans to build $20 bln mine, according to reports ), GOLD +0.5%, BHP +0.5% (reviewing options for its Nickel West business), SSRI +0.5%, GLD +0.1%.

A few India related names showing strength: IBN +2%, TTM +0.9%, INFY +0.6%.

A few solar names trading higher: CSIQ +1.5% (announces partnership with IKEA Australia to build 3.6MW solar system), YGE +6.6% (to provide engineering, procurement and construction services to the Electricity Generating Authority of Thailand for a 5 MW solar power plant in Thailand as a member of a four-party Consortium ).

Other news: PTX +12.1% (signs agreement to acquire TREXIMET Tablets for Migraine From GSK; co will make an upfront payment to GSK of $250 mln), ZTS +11.6% (still checking), CLDX +9.2% (Bristol-Myers and Celldex Therapeutics announce clinical trial collaboration to evaluate the combination of investigational immunotherapies nivolumab and varlilumab), ISIS +7.6% (reports Phase 2 data on ISIS-GCGR Rx showing significant reduction in HbA1c in patients with type 2 diabetes; greater than 2 percentage point reduction in HbA1c achieved after only 13 weeks of dosing ), SHLD +7.3% (Sears Hldg announced that it is exploring strategic alternatives for its 51% interest in Sears Canada), XON +5% (still checking), IMPV +3.7% ( may be attributed to positive CNBC Fast Money mention), MM +3.1% (Pres/CEO disclosed purchase of 291000 shares, worth total of $1002.7K ), TWGP +2.6% ( discloses dismissal of PwC, appointment of BDO as auditor), BLDP +1.9% (to power fuel cell hybrid bus at UC Irvine with partners BAE and ElDorado National), DXPE +1.9% (modestly rebounding), WMB +1% (Williams Cos, Williams Partners announce 2016 dividend and distribution growth guidance; WMB expects annual dividend growth of 20% through 2016 with substantial excess cash coverage and line of sight to continued high growth well beyond guidance period), AGN +0.8% (Valeant Pharma (VRX) and Pershing Square putting more pressure on AGN, according to reports), APC +0.7% (Announces 50% quarterly dividend increase to $0.27 per share),SGMS +0.6% ( CEO & CFO disclose stock purchases worth more than $500K ), WHR +0.5% (following positive Barron's mention), YHOO +0.5% (acquired Blink (Snapchat competitor), according to reports out last night), UA +0.4% (positive MadMoney mention), KORS +0.4% (following FOSL results), THRX +0.3% (GlaxoSmithKline disclosed purchase of 317,770 shares on 5/9).

Analyst comments: CAMP +4.9% (upgraded to Overweight from Equal Weight at First Analysis), MNKD +3.3% (upgraded to Neutral from Underweight at Piper Jaffray), INVN +1.5% (initiated at Imperial), AKAM +1.5% ( upgraded to Outperform from Sector Perform at Pacific Crest), P +1.4% (upgraded to Outperform from Market Perform at Raymond James), COHU +1.2% ( initiated with a Buy at B. Riley & Co), RCL +0.9% (upgraded to Buy from Neutral at SunTrust ), WDC +0.6% (upgraded to Overweight from Equal Weight at Barclays)